Daniel Finke

4PUBLICATIONS
31CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)MechanobiologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 18, 2026
MCL-1 inhibition triggers a largely reversible cardiac stress signature in a humanised mouse model.

|Jun 16, 2025
Feasibility Study for Long-Term Cardiotoxicity in Dose-Dense Treated Cancer Patients.

Markus B Heckmann, Julia Lehmann, Daniel Finke

|Aug 29, 2024
Transient Inhibition of Translation Improves Cardiac Function After Ischemia/Reperfusion by Attenuating the Inflammatory Response.

Christoph Hofmann, Adrian Serafin, Ole M Schwerdt

|Jun 15, 2023
Cardiomuscular Biomarkers in the Diagnosis and Prognostication of Immune Checkpoint Inhibitor Myocarditis.

Lorenz H Lehmann, Markus B Heckmann, Guillaume Bailly

Pageof 1

Frequent Collaborators

3 joint publications

Lorenz H Lehmann

3 joint publications

Markus B Heckmann

1 joint publications

Adrien Procureur

1 joint publications

John R Power